169 related articles for article (PubMed ID: 37274867)
1. Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment.
Sun Y; Liu Y; Chu H
J Immunol Res; 2023; 2023():2242577. PubMed ID: 37274867
[TBL] [Abstract][Full Text] [Related]
2. A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype.
Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
Front Immunol; 2021; 12():749459. PubMed ID: 34603338
[TBL] [Abstract][Full Text] [Related]
3. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
[TBL] [Abstract][Full Text] [Related]
4. An immune-related prognostic model predicts neoplasm-immunity interactions for metastatic nasopharyngeal carcinoma.
Chen X; Ding Q; Lin T; Sun Y; Huang Z; Li Y; Hong W; Chen X; Wang D; Qiu S
Front Immunol; 2023; 14():1109503. PubMed ID: 37063853
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumor-infiltrating immune cells and microenvironment-relevant genes in nasopharyngeal carcinoma based on gene expression profiling.
Zou Z; Ha Y; Liu S; Huang B
Life Sci; 2020 Dec; 263():118620. PubMed ID: 33096113
[TBL] [Abstract][Full Text] [Related]
6. Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy.
Li Z; Duan Y; Ke Q; Wang M; Cen H; Zhu X
Front Genet; 2022; 13():1000460. PubMed ID: 36276947
[No Abstract] [Full Text] [Related]
7. m6A Regulators Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization In Nasopharyngeal Carcinoma.
Liu Z; He J; Han J; Yang J; Liao W; Chen N
Front Immunol; 2021; 12():762243. PubMed ID: 35069534
[TBL] [Abstract][Full Text] [Related]
8. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes.
Zhang L; MacIsaac KD; Zhou T; Huang PY; Xin C; Dobson JR; Yu K; Chiang DY; Fan Y; Pelletier M; Wang Y; Jaeger S; Krishnamurthy Radhakrishnan V; JeBailey L; Skewes-Cox P; Zhang J; Fang W; Huang Y; Zhao H; Zhao Y; Li E; Peng B; Huang A; Dranoff G; Hammerman PS; Engelman J; Bitter H; Zeng YX; Yao Y
Mol Cancer Res; 2017 Dec; 15(12):1722-1732. PubMed ID: 28851814
[TBL] [Abstract][Full Text] [Related]
9. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.
Peng M
Front Immunol; 2022; 13():970885. PubMed ID: 36003383
[TBL] [Abstract][Full Text] [Related]
10. Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses.
Chen YP; Lv JW; Mao YP; Li XM; Li JY; Wang YQ; Xu C; Li YQ; He QM; Yang XJ; Lei Y; Shen JY; Tang LL; Chen L; Zhou GQ; Li WF; Du XJ; Guo R; Liu X; Zhang Y; Zeng J; Yun JP; Sun Y; Liu N; Ma J
Mol Cancer; 2021 Jan; 20(1):14. PubMed ID: 33430876
[TBL] [Abstract][Full Text] [Related]
11. Neoantigen landscape in metastatic nasopharyngeal carcinoma.
Lin M; Zhang XL; You R; Yang Q; Zou X; Yu K; Liu YP; Zou RH; Hua YJ; Huang PY; Wang J; Zhao Q; Jiang XB; Tang J; Gu YK; Yu T; He GP; Xie YL; Wang ZQ; Liu T; Chen SY; Zuo ZX; Chen MY
Theranostics; 2021; 11(13):6427-6444. PubMed ID: 33995666
[No Abstract] [Full Text] [Related]
12. A novel EIF3C-related CD8
Li R; Wang Y; Wen X; Cheng B; Lv R; Chen R; Hu W; Wang Y; Liu J; Lin B; Zhang H; Zhang E; Tang X
J Cancer Res Clin Oncol; 2024 Feb; 150(2):103. PubMed ID: 38400862
[TBL] [Abstract][Full Text] [Related]
13. Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis.
Zhao L; Fong AHW; Liu N; Cho WCS
J Biomed Sci; 2018 Feb; 25(1):16. PubMed ID: 29455649
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma.
Chen YP; Yin JH; Li WF; Li HJ; Chen DP; Zhang CJ; Lv JW; Wang YQ; Li XM; Li JY; Zhang PP; Li YQ; He QM; Yang XJ; Lei Y; Tang LL; Zhou GQ; Mao YP; Wei C; Xiong KX; Zhang HB; Zhu SD; Hou Y; Sun Y; Dean M; Amit I; Wu K; Kuang DM; Li GB; Liu N; Ma J
Cell Res; 2020 Nov; 30(11):1024-1042. PubMed ID: 32686767
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.
Lin W; Chen X; Huang Z; Ding Q; Yang H; Li Y; Lin D; Lin J; Zhang H; Yang X; Li C; Chen C; Qiu S
Br J Cancer; 2024 Apr; 130(7):1176-1186. PubMed ID: 38280969
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
17. The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma.
Zhou J; Guo T; Zhou L; Bao M; Wang L; Zhou W; Tan S; Li G; He B; Guo Z
Sci Rep; 2023 Feb; 13(1):1861. PubMed ID: 36732567
[TBL] [Abstract][Full Text] [Related]
18. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
Liu J; Li X; Yang S; Mou J; Lu H
Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Methods for Optimal Radiomics-Based Differentiation Between Recurrence and Inflammation: Application to Nasopharyngeal Carcinoma Post-therapy PET/CT Images.
Du D; Feng H; Lv W; Ashrafinia S; Yuan Q; Wang Q; Yang W; Feng Q; Chen W; Rahmim A; Lu L
Mol Imaging Biol; 2020 Jun; 22(3):730-738. PubMed ID: 31338709
[TBL] [Abstract][Full Text] [Related]
20. AURKA, as a potential prognostic biomarker, regulates autophagy and immune infiltration in nasopharyngeal carcinoma.
Jiang D; Chen H; Cao J; Chen Y; Huang J; Weng Y
Immunobiology; 2023 Mar; 228(2):152314. PubMed ID: 36587494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
